0001437749-21-014028.txt : 20210603
0001437749-21-014028.hdr.sgml : 20210603
20210603084102
ACCESSION NUMBER: 0001437749-21-014028
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210419
FILED AS OF DATE: 20210603
DATE AS OF CHANGE: 20210603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Byrne Joseph A.
CENTRAL INDEX KEY: 0001736911
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55557
FILM NUMBER: 21991306
MAIL ADDRESS:
STREET 1: 6 CAMERON SIDE ROAD EAST
CITY: ESSEX
STATE: A6
ZIP: N8M 2X5
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEN BIOTECH INC
CENTRAL INDEX KEY: 0001653821
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
BUSINESS PHONE: 226-344-0660
MAIL ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
3
1
rdgdoc.xml
FORM 3
X0206
3
2021-04-19
0
0001653821
CEN BIOTECH INC
CENBF
0001736911
Byrne Joseph A.
300-3295 QUALITY WAY
WINDSOR, ONTARIO, CANADA
A6
N8T 3R9
ONTARIO, CANADA
1
1
President
Common Stock
1364894
D
Common Stock
164000
I
By Spouse
Common Stock
1.6000
2016-08-17
2020-08-17
Common Stock
76123
D
Joseph Byrne (the "Reporting Person") was appointed to his positions with CEN Biotech, Inc. (the "Issuer") on April 19, 2021 and owned 1,362,894 shares of the Issuer's common stock at such date.
The Reporting Person also beneficially owns a convertible note with 76,123 shares issuable upon conversion of same.
/s/ Joseph Byrne
2021-06-03